The effect of complementary and alternative medicines on CYP3A4-mediated metabolism of three different substrates: 7-benzyloxy-4-trifluoromethyl-coumarin, midazolam and docetaxel

Development and validation of a LC-MS/MS method for thein vitroanalysis of 1-hydroxymidazolam in human liver microsomes: application for determining CYP3A4 inhibition in complex matrix mixtures

(2013) K. D. Mooiman et al.   BIOMEDICAL CHROMATOGRAPHY

Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb–drug interactions in cancer patients

(2013) Andrew K.L. Goey et al.   CANCER TREATMENT REVIEWS

Quantification of docetaxel and its metabolites in human plasma by liquid chromatography/tandem mass spectrometry

(2013) J. J. M. A. Hendrikx et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY

System-Dependent Outcomes during the Evaluation of Drug Candidates as Inhibitors of Cytochrome P450 (CYP) and Uridine Diphosphate Glucuronosyltransferase (UGT) Enzymes: Human Hepatocytes versus Liver Microsomes versus Recombinant Enzymes

(2010) Andrew Parkinson et al.   Drug Metabolism and Pharmacokinetics

Effects of herbal products on the metabolism and transport of anticancer agents

(2010) Shu-Ming He et al.   Expert Opinion on Drug Metabolism & Toxicology

Safety of Herbal Medicinal Products: Echinacea and Selected Alkylamides Do Not Induce CYP3A4 mRNA Expression

(2009) Maryam Modarai et al.   Evidence-based Complementary and Alternative Medicine

In vitroinhibition of CYP3A4 by herbal remedies frequently used by cancer patients

(2009) Silje Engdal et al.   PHYTOTHERAPY RESEARCH

In vitroCYP3A4 Metabolism: Inhibition byEchinacea purpureaand Choice of Substrate for the Evaluation of Herbal Inhibition

(2008) Torstein Schrøder Hansen et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

In vitro Inhibition of CYP3A4 Metabolism and P-Glycoprotein-Mediated Transport by Trade Herbal Products

(2008) Bent H. Hellum et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Retinoids induce cytochrome P450 3A4 through RXR/VDR-mediated pathway

(2008) Kun Wang et al.   BIOCHEMICAL PHARMACOLOGY

Identification of Ginkgo biloba as a Novel Activator of Pregnane X Receptor

(2008) E. Y. H. Yeung et al.   DRUG METABOLISM AND DISPOSITION

Activation of Pregnane X Receptor and Induction of MDR1 by Dietary Phytochemicals

(2008) Hideo Satsu et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Bioactive Terpenoids and Flavonoids from Ginkgo Biloba Extract Induce the Expression of Hepatic Drug-Metabolizing Enzymes Through Pregnane X Receptor, Constitutive Androstane Receptor, and Aryl hydrocarbon Receptor-Mediated Pathways

(2008) Linhao Li et al.   PHARMACEUTICAL RESEARCH

Structure-Activity Relationship and Substrate-Dependent Phenomena in Effects of Ginsenosides on Activities of Drug-Metabolizing P450 Enzymes

(2008) Miao Hao et al.   PLoS One

Assessment of drug–drug interaction for silymarin

(2008) Johannes Doehmer et al.   TOXICOLOGY IN VITRO